Patents by Inventor Thomas SCHUERPF

Thomas SCHUERPF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER USING ANTI-DDR1 ANTIBODIES AND IMMUNE CHECKPOINT INHIBITORS
    Publication number: 20260199458
    Abstract: Provided are methods and dosage regimens for treating cancer using an antibody that specifically binds to human DDR1 and an immune checkpoint inhibitor.
    Type: Application
    Filed: November 15, 2023
    Publication date: July 16, 2026
    Inventors: Laurent Audoly, Laura Dillon, Thomas Schuerpf, Joseph Eder, Guy Travis Clifton, Yan Qin
  • METHODS OF TREATING CANCER USING ANTI-DDR1 ANTIBODIES
    Publication number: 20260184795
    Abstract: Provided are methods and dosage regimens for treating cancer using an antibody that specifically binds to human DDR1.
    Type: Application
    Filed: November 15, 2023
    Publication date: July 2, 2026
    Inventors: Laurent Audoly, Laura Dillon, Thomas Schuerpf, Joseph Eder, Guy Travis Clifton, Yan Qin
  • METHODS OF DETECTING DDR1 PHOSPHORYLATION
    Publication number: 20250369982
    Abstract: The instant disclosure provides methods of detecting discoidin domain receptor tyrosine kinase 1 (DDR1) phosphorylation to determine the effectiveness or likely effectiveness of DDR1 antagonistic therapies. The disclosure provides antibodies for use in the treatment of DDR1 related disorders that specifically bind to DDR1. Also provided herein are compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, for detecting phosphorylated DDR1.
    Type: Application
    Filed: June 16, 2023
    Publication date: December 4, 2025
    Inventors: Glenn BEGLEY, Thomas SCHUERPF, Laurent AUDOLY